Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 6, 2007, Pages 1355-1360

  Cheong, Hae Suk ^a   Kang, Cheol In ^a   Kwon, Ki Tae ^b   Heo, Sang Tack ^c   Wi, Yu Mi ^a   Kim, Eun Seok ^a   Lee, Jin Seo ^a   Ko, Kwan Soo ^a,d   Chung, Doo Syeon ^a   Lee, Nam Yong ^a   Song, Jae Hoon ^a,d   Peck, Kyong Ran ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Daegu Fatima Hospital   (South Korea)

^c Gyeongsang National University   (South Korea)

^d Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

Author keywords

Antimicrobial resistance; Inappropriate therapy; Mortality

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; COHORT ANALYSIS; COMMUNITY; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; EMERGENCY WARD; ESCHERICHIA COLI; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS;

EID: 36448935670     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm378     Document Type: Article

References (20)

1. Diekema DJ, Pfaller MA, Jones RN et al. Survey of bloodstream infections due to gram-negative bacilli: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997. Clin Infect Dis 1999; 29: 595-607.
2. Weinstein MP, Towns ML, Quartey SM et al. The clinical significance of positive blood cultures in the 1990s: A prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungernia in adults. Clin Infect Dis 1997; 24 584-602.
3. Diekema DJ, Pfaller MA, Jones RN. Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America: SENTRY Antimicrobial Surveillance Program, 1997-2000. Int J Antimicrob Agents 2002; 20: 412-8.
4. Kem WV, Andriof E, Oethinger M et al. Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center. Antimicrob Agents Chemother 1994; 38: 681-7.
5. Lautenbach E, Strom BL, Bilker WB et al. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis 2001; 33: 1288-94.
6. Garau J, Xercavins M, Rodriguez-Carballeira M et al. Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother 1999; 43: 2736-41.
7. Pena C, Albareda JM, Pallares R et al. Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections. Antimicrob Agents Chemother 1995; 39: 520-4.
8. Cheong HJ, Yoo CW, Sohn JW et al. Bacteremia due to quinolone-resistant Escherichia coli in a teaching hospital in South Korea. Clin Infect Dis 2001; 33: 48-53.
9. McDonald JR, Friedman ND, Stout JE et al. Risk factors for ineffective therapy in patients with bloodstream infection. Arch Intern Med 2005; 165: 308-13.
10. Friedman ND, Kaye KS, Slout JE et al. Health care-associated bloodstream infections in adults: A reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137: 791-7.
11. Chow JW, Yu VL. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: A commentary. Int J Antimicrob Agents 1999; 11: 7-12.
12. Lesens O, Methlin C, Hansmann Y et al. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: A prospective study using the Charison weighted index of comorbidity. Infect Control Hosp Epidemiol 2003; 24: 890-6.
13. Kang CI, Kim SH, Park WB et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: Risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005; 49: 760-6.
14. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Fifteenth Informational Supplement M100-S15. CLSI, Wayne, PA, USA, 2005.
15. Sun HY, Chen SY, Chang SC et al. Community-onset Escherichia coil and Klebsiella pneumoniae bacteremia: Influence of health care exposure on antimicrobial susceptibility. Diagn Micrabiol Infect Dis 2006; 55: 135-41.
16. Ramphal R, Ambrose PG. Extended-spectrum β-lactamases and clinical outcomes: Current data. Clin Infect Dis 2006; 42 Suppl 4: S164-72.
17. Kim YK, Pai H, Lee HJ et al. Bloodstream infections by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: Epidemiology and clinical outcome. Antimicrob Agents Chemother 2002; 46: 1481-91.
18. Ho PL, Chan WM, Tsang KW et al. Bacteremia caused by Escherichia coli producing extended-spectrum β-lactamase: A case-control study of risk factors and outcomes. Scand J Infect Dis 2002; 34: 567-73.
19. Zaragoza R, Artero A, Camarena JJ et al. The influence of inadequate empirical antimicrobial treatment on patients with blood-stream infections in an intensive care unit. Clin Microbiol Infect 2003; 9: 412-8.
20. Valles J, Rello J, Ochagavia A et al. Community-acquired blood-stream infection in critically ill adult patients: Impact of shock and inappropriate antibiotic therapy on survival. Chest 2003; 123: 1615-24.